With innovations from Novo Nordisk, Eli Lilly and Company, Amgen, Boehringer Ingelheim, Zealand Pharma, Altimmune and Roche, the pipeline is packed with promising candidates targeting GLP-1 + GIP, glucagon, and amylin
Ada Enesco, EMJ Reference Kindel TL et al
In addition to weight loss, semaglutide can also improve metabolic health markers, such as blood sugar and cholesterol levels
10.1016/j.jjcc.2014.11.001 30
Novel pharmacologic approaches to the prevention and treatment of ulcerative colitis
According to the company's website, MEDVi is partnered with multiple certified pharmacies in the United States to dispense medications